To test the hypothesis, we examined the expression of EIF4EBP1 at mRNA and protein levels in the paired HCC and NCL samples using qRT-PCR, Western blot and immunohistochemistry and then evaluated the clinical significance of its protein expression. Here, EIF4EBP1 is linked to hepatocellular carcinoma.